WO2007003431A1 - Dispositif et procédé de distribution et d'élimination de substances provenant et à destination d'un tissu ou d'un vaisseau - Google Patents

Dispositif et procédé de distribution et d'élimination de substances provenant et à destination d'un tissu ou d'un vaisseau Download PDF

Info

Publication number
WO2007003431A1
WO2007003431A1 PCT/EP2006/006568 EP2006006568W WO2007003431A1 WO 2007003431 A1 WO2007003431 A1 WO 2007003431A1 EP 2006006568 W EP2006006568 W EP 2006006568W WO 2007003431 A1 WO2007003431 A1 WO 2007003431A1
Authority
WO
WIPO (PCT)
Prior art keywords
tissue
substances
porous
substance
vessel
Prior art date
Application number
PCT/EP2006/006568
Other languages
English (en)
Other versions
WO2007003431A9 (fr
Inventor
Werner Regittnig
Original Assignee
Medizinische Universität Graz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medizinische Universität Graz filed Critical Medizinische Universität Graz
Priority to EP06762426A priority Critical patent/EP1898799A1/fr
Priority to US11/994,739 priority patent/US20080234563A1/en
Publication of WO2007003431A1 publication Critical patent/WO2007003431A1/fr
Publication of WO2007003431A9 publication Critical patent/WO2007003431A9/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14503—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14525—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using microdialysis
    • A61B5/14528—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using microdialysis invasively
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/686—Permanently implanted devices, e.g. pacemakers, other stimulators, biochips

Definitions

  • the invention relates to a device for delivery of substances to and removal of bodily substances from a tissue or vessel of a body with an element to be positioned in the tissue or vessel.
  • transcutaneous indwelling catheters In order to reduce the number of needle sticks required and the pain and unpleasantness connected therewith during repeated introductions and removals of substances, different types of catheters have been developed which may be implanted in a bodily region and then allow access to this bodily region over a longer period of time. Depending on the type of the implanted indwelling catheter , this access provided may be used for delivery of substances to this bodily region and/or for removal of bodily substances from this bodily region.
  • An example of this would be the transcutaneous indwelling catheter, via which patients having type 1 diabetes may be supplied with insulin continuously into the subcutaneous adipose tissue.
  • Typical transcutaneous indwelling catheters are composed of stiff hollow needles or soft cannulas, which may be inserted by the patient into the subcutaneous tissue of the abdomen, fixed with an adhesive strip, and connected to an insulin pump using tubing.
  • US 5,257,980 describes a flexible, transcutaneous cannula, which is introduced by the patient into the subcutaneous tissue with the aid of a metal needle and then may dwell for a long time in the tissue after removal of the metal needle.
  • Transcutaneous indwelling catheters of this type may only be used for delivery of substances to tissue. Removal of substances from tissue, for example glucose for the purpose of determining the tissue glucose concentration, is not possible using these indwelling catheters.
  • indwelling catheters which are suitable both for the delivery and also for the removal of substances would be types of catheters which operate according to the principles of microdialysis, ultrafiltration, or microperfusion.
  • US 5,741,284 describes an indwelling catheter operating according to the principle of microdialysis.
  • This catheter has a membrane positioned at the end of the catheter and is introduced into the tissue using a hollow needle enveloping the membrane. After removal of the hollow needle, the catheter is perfused with an isotonic fluid.
  • concentration differences between the materials dissolved in the perfusate fluid and the materials dissolved in the tissue fluid there is a diffusion-driven transport of substances through the catheter membrane and thus an exchange of substances between perfusate fluid and tissue fluid.
  • materials from the tissue fluid may thus be brought via the membrane into the perfusate fluid or perfusate fluid materials may be brought via the membrane into the tissue.
  • Microdialysis catheters have a very low mechanical strength because of the thin membrane, due to which the introduction and removal of the catheter has been shown to be difficult and complex.
  • the manufacturing of microdialysis catheters of this type is relatively costly.
  • US 6,706,009 B2 describes an indwelling catheter which operates according to the principle of open microperfusion.
  • This catheter comprises a cannula provided with macroscopic perforations and is introduced into the tissue using a metal needle positioned in the cavity of the cannula. After removal of the metal needle, the perforated cannula is perfused with an isotonic fluid.
  • concentration differences between the materials dissolved in the perfusate fluid and the materials dissolved in the tissue fluid there is a diffusion-driven transport of substances - A -
  • microperfusion catheters of this type are more stable than microdialysis or ultrafiltration catheters because the thin membrane is dispensed with, but their exchange of substances is less efficient in comparison thereto.
  • microperfusion catheters may be equipped with an increased number of perforations. This increase in efficiency is at the cost of significantly larger constructions and therefore more difficult placement of the catheters.
  • Diabetes is one of the most frequent chronic illnesses worldwide. Diabetes is characterized by the loss of insulin production of the pancreas (type 1 diabetes) or by an abnormal insulin secretion of the pancreas (type 2 diabetes).
  • type 1 diabetes In order to avoid states of high blood glucose concentration (hyperglycemia) and their acute life- threatening consequences (ketoacidosis) and also chronic consequences (e.g.: blindness, amputation, kidney failure), patients having type 1 diabetes must be externally supplied with insulin. Patients having type 2 diabetes must also be supplied with insulin if a reduction of the blood glucose level may not be achieved by diet and by giving oral antidiabetic agents.
  • Insulin is introduced by a majority of type 1 diabetic patients multiple times a day into the adipose tissue located under the skin (subcutaneous insulin injection) using an injection needle.
  • An increasing number of type 1 diabetic patients are using an insulin pump and a transcutaneous indwelling catheter worn therewith for the continuous supply of insulin.
  • This so-called insulin pump therapy represents the most effective form of therapy for type 1 diabetes at this time.
  • a large difficulty in insulin substitution is adapting the insulin dose to the existing blood glucose concentration. Thus, for example, if too high a dose is selected, too strong a glucose reduction and a life-threatening state (coma due to hypoglycemia) connected thereto may be provoked.
  • US 5,325,867 discloses a device for the sampling of body fluids using a hollow needle, and is provided with a storage system with several separate sample containers placed on a movable carrier.
  • the containers which are sealed by puncturable membranes so as to be gas-tight, will receive collected fractions of the body fluid at given intervals, a device connected to a control unit being provided, by which the hollow needle is positioned over each sample container in turn and is inserted through the membrane into the sample container.
  • the sampling device is configured as a two-channel cannula, one of whose channels is connected via a first connecting tube to the hollow needle used for insertion into the sample containers, while its other channel is connected via a second connecting tube to a pump operated by the control unit.
  • EP 0,958,780 Al discloses an implanted depot dispensing measured quantities of a medical substance like insulin, joined to the skin with small disks and equipped with an elastic self closing membrane, has a supply catheter and a suction catheter attached to its bottom.
  • the supply catheter is used for the insertion of a medical substance, the suction catheter facilitates the removal of body fluids for diagnostic purposes.
  • a sensor can be attached to the suction tube in order to allow a check of the body fluid already inside the body.
  • DE 31 12 762 Al discloses a catheter set which permits continuous withdrawal of blood via a central access to a vessel and simultaneous infusion of solutions distally thereof, which is required in medicine, in particular for systems in which infusions are controlled via a computer in accordance with a current blood value, e.g. glucose. It comprises two channels which are to be tightly connected, and an axial catheter fixed to the channel by a stopper strip and a union nut. Infusion can be made through the axial catheter, an anticoagulant solution can be fed in between the catheter and the inner channel, the solution being mixed with the blood between the sleeve end of the outer and inner channels, and a mixture of blood and anticoagulant can be sucked in between the inner and outer channels.
  • a current blood value e.g. glucose
  • the term "substance” generally includes greatly varying fluids having materials dissolved therein or also greatly varying gases.
  • body substances generally includes all substances which occur in the surroundings of the element positioned in the tissue or vessel.
  • porous material may particularly denote any material comprising pores or vessels or holes, particularly in the dimension of nanometres, micrometres, or millimetres. Such pores may be three-dimensional structures in a solid body. A plurality of such interconnected pores formed in a solid body may (for instance statistically) form pathways in the material through which particularly fluidic samples may move or penetrate. For instance, a sintered body, soil, or a rock may comprise pores.
  • the porous element may be a network of interconnected pores through which fluids having materials dissolved therein can be conducted. At the surface of such a porous structure, a contact and an exchange between the perfusion fluid and the surrounding tissue or vessel fluid may be enabled.
  • the pore size and density may be configured in such a manner that, when forming a pressure difference between an inlet and an outlet, the fluidic flow may be maintained in the porous structure without "sucking" the surrounding tissue or vessel components (for instance cells having a size of 10 ⁇ m to 150 ⁇ m or capillaries having a length of 500 ⁇ m and a thickness of 7 ⁇ m), which might cause surface portions of the pores to be closed or blocked. This can happen with very large pores sizes which may therefore be less favourable.
  • the pore size may be smaller than 200 ⁇ m, since with significantly larger pore sizes it is believed that cells and capillaries may be pressed into the pores.
  • extremely small pores (less or significantly less than 0.1 ⁇ m) may have a hydraulic conductivity being much less than that of the surrounding tissue. The pressure difference required for the solution to penetrate the porous element might then be so large that the surrounding tissue or vessel structures may be harmed or damaged.
  • Porous elements may be manufactured by sintering polymers, ceramics or metals in granular shape. Also sintering metallic fibres may generate a porous structure.
  • a further efficient method for manufacturing porous plastic structures is expanding specific plastics (like expanded polytetrafluoroethylene (ePTFE) or expanded fluorinated ethylene propylene (eFEP)).
  • specific plastics like expanded polytetrafluoroethylene (ePTFE) or expanded fluorinated ethylene propylene (eFEP)).
  • porous metal, porous ceramics, and porous polymer layers may be manufactured (for example titanium coating, ceramic coating, polymer coating).
  • porous material may also include patterned rough surfaces (surface texturing).
  • rough surfaces including for example surface grooves, surface channels, surface pyramids
  • appropriate dimensions like in the order of magnitude of 1 ⁇ m
  • Methods that may be applied for patterning surfaces of metals, polymers, and/or ceramics are, for example, ion beam texturing, laser beam texturing, imprint lithography, microcontact printing, catalytic growth, or thin film coating.
  • a device for delivery and removal of substances which has a smaller and more robust construction than known indwelling catheters having comparable function and which may be used as easily and comfortably as possible by a patient.
  • the device may also be suitable for a mass production at relatively low production costs and therefore also may be accessible to a broad circle of patients, for example, for the therapy of diabetes.
  • a system which allows a proper simulation of the glucose-regulating function of a healthy pancreas over a long possible period of time and may thus be used for the therapy of type 1 diabetes.
  • the system may be constructed as small and compactly as possible and should be able to be worn comfortably on the body.
  • a method is provided which allows a proper simulation of the glucose-regulating function of a healthy pancreas over a long period of time.
  • the removal of glucose from a tissue or vessel and the delivery of insulin to the tissue or vessel is to be able to be performed efficiently by the method according to the invention.
  • a component of embodiments of the invention is at least partially formed by porous material.
  • the porous material comprises multiple pores which are interconnected, so that fluids and materials dissolved therein may be conducted through the porous material.
  • the porous material may be implemented in multiple shapes and sizes.
  • the porous material may be designed as rod-shaped, tube-shaped, or plate-shaped.
  • a system according to an exemplary embodiment of the invention also comprises an inlet line and a drain line that permit a fluid reservoir and a fluid collector to be placed in fluid communication with the porous material.
  • the inlet line and drain line also allow a pressure differential, from a source external to the porous material, to be applied to surface regions of the porous material to promote controlled fluid movement through the porous material.
  • a pressure differential from a source external to the porous material, to be applied to surface regions of the porous material to promote controlled fluid movement through the porous material.
  • the pressure differential can be created readily through use of a pumping system and applied to the porous material either in the form of positive pressure (so-called push mode), negative pressure (so called pull mode), or both (so-called push-pull mode).
  • the device is placed into the selected tissue or vessel in such a way that the surface of the porous material is enclosed by the tissue or vessel, thereby allowing the porous material to be isolated or partitioned from the environment outside the tissue or vessel (e.g., air and atmospheric pressure).
  • the environment outside the tissue or vessel e.g., air and atmospheric pressure.
  • fluids and materials dissolved therein can then be drawn from the reservoir outside the body, into the inlet line, through the porous material, through the drain line, and into a collector outside the body. Because of concentration differences between the substances located in the porous material and the substances located in the tissue and/or because of pressure differences between porous material and tissue, an exchange of substances between the porous material and the surrounding tissue is caused during the flow through the porous material.
  • substances may therefore be conveyed from the porous material into the tissue and/or substances may be conveyed from the tissue into the porous material.
  • substances After flowing through the porous material, substances are moved from the porous material via the drain line connected to the outlet to a sensor and/or a collection container. Therefore, a substance, particularly a medication, such as insulin, may be delivered and also, preferably for the purpose of regulating the delivery of the substance, the concentration of specific bodily substances, such as the tissue glucose concentration, may be measured via one and the same implant, in that tissue fluid or blood plasma is removed and supplied to a sensor for determining the concentration of the materials dissolved therein.
  • the device is distinguished by its special simplicity and is therefore producible very easily and cost-effectively.
  • the device according to the invention combines the advantages of known microdialysis and ultrafiltration catheters with those of known microperfusion catheters, so that a more efficient substance exchange and a high degree of robustness result.
  • the element to be positioned in the tissue or vessel may be made at least partially of porous metal, porous ceramic material, or porous plastic, and should have biocompatible properties.
  • An number of materials such as polyethylene (PE) or polytetrafluorethylene (PTFE), are biocompatible and may be manufactured having a porous structure and in different shapes and sizes easily through sintering, for example.
  • the size of the pores of the porous material is, for example, 0.02 ⁇ m to 200 ⁇ m.
  • the pore size is, of course, dependent on the substance to be delivered and/or the bodily substances to be extracted and has to be adapted to the particular conditions.
  • the element is at least partially made of hydrophobic porous material.
  • advantages for the delivery of substances may be achieved through a hydrophobic implementation of the surface.
  • the element is at least partially made of hydrophilic porous material.
  • a hydrophilic surface of the porous material may particularly be advantageous for the extraction of bodily substances from the tissue or vessel.
  • advantages may be achieved through combinations of hydrophobic and hydrophilic surfaces of the porous material.
  • the element is formed by a rod made of the porous material, the inlet for connecting the inlet line for the connection to the container for the substance to be delivered being positioned at one end of the rod and the outlet for connecting the drain line for draining the extracted bodily substances being positioned at the other end of the rod, so that the delivery of the substance to the tissue or into the vessel and the extraction of the bodily substances from the tissue or vessel occurs via the mantle surface of the rod.
  • Central element is the rod made of porous material, such as porous plastic, which may be produced from particles made of biocompatible polyethylene (PE) through sintering, for example.
  • the inlet line for the substances to be delivered and the drain line for the removal of the bodily substances from the tissue or vessel may also be made of the base material of the element.
  • the oblong element is preferably placed in the tissue or vessel with the aid of a hollow needle and the ends are connected to the corresponding lines.
  • the substance to be delivered is pumped into the element made of porous material with the aid of a pump and partially delivered to the tissue or into the vessel.
  • the substances extracted via the mantle surface of the porous rod are transported via the drain line to a sensor, for example, and, after determining the concentration of the substances, are transported further to a collection container.
  • This embodiment variation has the disadvantage that the skin must be tunnelled under and therefore must be penetrated twice to place the device.
  • the reinforcement element is preferably made of nonporous material.
  • the element to be positioned in the tissue or vessel and possibly the reinforcement element is/are preferably made of flexible material. This makes the introduction of the device into the tissue or vessel easier and reduces pain and unpleasantness during wearing thereof.
  • the element is formed by a tube made of the porous material, an inlet tube made of nonporous material being positioned in the cavity of the tube, a connection element for connecting the inlet line for the connection to the container for the substance to be delivered being positioned at one end of the tube, this substance being conveyed via the inlet tube to the at least one inlet located at the free end of the tube, and the at least one outlet for the connection to the drain line for removal of the bodily substances from the tissue or vessel extracted via the porous material of the tube being positioned on the connection element.
  • connection for connecting to the inlet line for supplying the substance to be delivered is connected to the end of the nonporous inlet tube located there, so that if a differential pressure builds up between the inlet line and the drain line, fluids and materials dissolved therein may be conveyed from a container outside the tissue or vessel via the cavity of the inlet tube to the free end of the porous element and may be conducted from there through the porous material. While flowing through the porous material along the longitudinal axis of the element, substances may pass from the porous material into the tissue and substances may also pass from the tissue into the porous material.
  • the attachment element preferably has a hole discharging into the cavity of the inlet tube and a hole positioned on the front side of the end of the porous tube, which is connected to a hole discharging into the drain line.
  • the free end of the porous tube and possibly the nonporous inlet tube may be implemented as beveled. If stiff porous materials and/or stiff nonporous inlet tube materials are used, the device may thus also be inserted directly into the tissue or vessel.
  • the porous tube and possibly the nonporous inlet tube may be made of flexible material, which allows more comfortable wearing of the device.
  • connection element may also have a hole, which corresponds to the cavity of the inlet tube, for inserting a needle.
  • a needle inserted via the hole into the cavity of the inlet tube allows easier placement of the device in the tissue or vessel.
  • the needle is removed and the hole is preferably provided with a cover element.
  • the nonporous inlet tube may be formed by an axially displaceable hollow needle.
  • the needle is advanced when the device is placed, so that the tip of the needle projects out of the porous tube and easier introduction of the device into the tissue or vessel is thus made possible.
  • the needle is retracted, so that the tip of the needle is also enclosed by the porous tube and therefore more comfortable wearing of the device is made possible.
  • the inlet line, drain line, and the porous element and possibly the connection element and the inlet tube may be glued, welded, or press fit with one another. Arbitrary combinations of these connection techniques are possible.
  • the inlet line, drain line, possibly the connection element, and the inlet tube may also be integrally formed with the porous element.
  • a system may be provided for delivery of substances to a tissue or vessel depending on the concentration of a bodily substance in the tissue or vessel having a device described above, at least one container for the substance to be delivered, at least one pump for draining the extracted bodily substance, a sensor for measuring the concentration of the bodily substance, a unit for calibrating the measurement of the concentration of the bodily substance, a unit for regulating the quantity of the substance to be delivered depending on the measured concentrations of the bodily substance, and a collection container for the extracted substances.
  • the delivery of insulin to subcutaneous tissue depending on the measured tissue glucose concentration is thus possible in particular.
  • the at least one container for the substance to be delivered, the at least one pump, the sensors, the calibration unit, the regulatory unit, and the collection container are preferably positioned in a shared housing.
  • the unit for calibrating the measurement of the tissue concentration of the bodily substances is advantageously formed by a unit for measuring at least one value of at least one marker parameter of the extracted tissue fluid.
  • a marker parameter may be the conductivity of the extracted tissue fluid
  • explicit reference is made to the disclosure with respect to calibration using endogenous and/or exogenous marker parameters of WO 88/05643.
  • the sensor for measuring the concentration of the bodily substance and the calibration unit are integrated in the device. Using such an arrangement, one fluid line may be dispensed with and may be replaced by a line having a comparatively rapid signal transmission.
  • bodily substances being removed at the location of the tissue or vessel at which the substance is delivered and being supplied to a sensor for measuring the concentration of the bodily substance using the same element. Because at least one substance is introduced into the tissue or vessel and also at least one bodily substance is removed from the tissue or blood to measure its concentration using one single element, a lower stress of the patient results, since only one element must be introduced into the tissue or vessel.
  • tissue fluid is removed to measure the tissue glucose concentration and the dose of the insulin to be delivered is regulated in accordance with the measured tissue glucose concentration.
  • a so-called closed loop system is thus provided, which simulates the glucose-regulating function of a healthy pancreas.
  • the measurement of the tissue glucose concentration is preferred to the measurement of the blood glucose concentration because of the risks in connection with continuous blood glucose measurement, such as infections, hemorrhages, and blood clotting.
  • the tissue glucose concentration correlates very well with the blood glucose concentration.
  • Tissue fluid is advantageously removed continuously and therefore, for example, tissue glucose concentration is ascertained continuously, through which both timely detection of small blood glucose setpoint value deviations and also a timely correction of these deviations are made possible by adapting the insulin supply, so that pronounced hypoglycemia and hyperglycemia may be effectively avoided during treatment.
  • the measurement of the tissue glucose concentration is preferably calibrated permanently to be able to make a reliable statement about the actual blood glucose concentration.
  • Figure 1 shows a schematic sectional diagram of a stiff, hollow transcutaneous needle for the subcutaneous delivery of a substance using a pump
  • Figures 2A and 2B show schematic sectional images of a flexible, transcutaneous cannula for the subcutaneous administration of a substance using a pump;
  • Figure 3 shows an embodiment of the device according to the invention in a sectional image
  • Figure 4 shows the device shown in Figure 3 during the procedure of placement in the subcutaneous tissue
  • Figure 5 shows a further embodiment of the device having a reinforcement element
  • Figure 6A shows a further embodiment of a device having a tubular porous element
  • Figure 6B shows a section through the device along the section line B-B in Figure 6A;
  • Figures 7 A and 7B show a further embodiment of the present invention.
  • Figures 8 A and 8B show a further embodiment of the device
  • Figures 9A and 9B show a use of the device shown in Figures 8 A and 8B in a vessel
  • Figure 10 shows the use of the embodiment of the device shown in Figure 6 in a vessel
  • Figures 1 IA and 1 IB show a further embodiment of the device according to the invention during use in a vessel
  • Figure 13 and Figure 14 show two further embodiments of an apparatus for the simultaneous delivery of a substance to the subcutaneous tissue and extraction of bodily substances from the subcutaneous tissue using a device according to the invention.
  • FIG. 1 shows a sectional image of a transcutaneous needle 1 made of metal as is used for the delivery of substances 9, such as insulin, with the aid of a pump (not shown).
  • the needle 1 is inserted by the patient himself into the subcutaneous tissue 2 and connected to a line for supplying the substance 9 from a container (not shown).
  • the substance 9 and/or the insulin is delivered through the hollow needle 1 into the subcutaneous tissue 2.
  • Transcutaneous needles 1 of this type are unsuitable for the removal of bodily substances from the subcutaneous tissue 2.
  • FIGs 2A and 2B show a flexible, transcutaneous cannula 3 as is used, for example, in the therapy of diabetes with the aid of insulin pumps.
  • the cannula 3 made of elastic material is inserted by the patient himself into the subcutaneous tissue 2 with the aid of a hollow needle 1 made of metal. After the insertion, the hollow needle 1 is removed as shown in Figure 2B and the opening is closed by a cover element 4.
  • the cannula 3 to a corresponding line (not shown) for supplying the substance 9 to be delivered, such as insulin
  • the delivery of the substance 9 to the subcutaneous tissue 2 may be performed.
  • Cannulas 3 of this type offer increased wearing comfort due to the elevated elasticity of the materials used.
  • transcutaneous cannulas 3 of this type are also unsuitable for removing bodily substances from the subcutaneous tissue 2.
  • Figure 3 shows a first embodiment of the present invention having a device 5 for delivery and removal of substances 9 and 22, respectively, using an element 6 to be positioned in the tissue 2 having an inlet 7 for supplying the substances 9 to be delivered and an outlet 10 for draining the bodily substances 22 removed.
  • the inlet 7 is connected via an inlet line 13 to a container (not shown) for the substance 9 to be delivered and/or multiple containers for the substances 9 to be delivered.
  • a corresponding drain line 12 is positioned at the outlet 10, via which the bodily substances 22 and possibly undelivered substances 9 may be drained.
  • the element 6 comprises a rod 8 made of porous material.
  • the substances 9 to be delivered are introduced via the inlet 7 into the end of the rod 8 made of porous material and conducted through the pores of the porous material in the direction of the opposite end of the rod 8. Because of concentration differences between the substances in the porous material of the rod 8 and the substances in the tissue 2 and/or because of pressure differences between porous material and tissue 2, substances 9 may be conveyed from the porous material of the rod 8 into the tissue 2 and/or bodily substances 22 may be conveyed from the tissue 2 into the porous material of the rod 8 while flowing through the porous material.
  • the extracted bodily substances 22 and possibly the undelivered residue of the substances 9 are drained via the drain line 12 connected to the outlet 10.
  • the device 5 is placed at a suitable location of the tissue 2 and thus allows both the delivery of a substance 9 to the tissue 2 and also the extraction of bodily substances 22 from the tissue fluid of the tissue 2. This embodiment variation is especially suitable for use in the subcutaneous tissue 2. A use of the device 5 in other tissue parts of the human or animal body and in vessels, particularly blood vessels, is also possible.
  • Figure 4 shows the device 5 according to Figure 3 during the introduction into the subcutaneous tissue 2.
  • the rod 8 which is preferably made of flexible porous material, is introduced into the subcutaneous tissue 2 with the aid of the needle 11 which is mounted on a drain line 12 connected to the outlet 10.
  • the inlet line 13 and drain line 12 may be glued, welded, press fit or integrally formed with the element 6 and/or rod 8.
  • the inlet line 13 may also be plugged onto the inlet 7 and the drain line 12 may be plugged onto the outlet 10.
  • the pressure difference between the inlet line 13 connected to the inlet 7 and the drain line 12 connected to the outlet 10 may be built up to convey the substances 9, 22 in the lines 13, 12 and in the porous rod 8 by a corresponding pump system (not shown) in the form of a positive pressure (so-called push mode), a negative pressure (so-called pull mode), or both a positive and also a negative pressure (push-pull mode).
  • the device 5 according to Figures 3 and 4 is characterized by a simple construction and may therefore be produced cost-effectively. During placement of the device 5 in the tissue 2 or vessel, the skin has to be tunneled under, however, and therefore the skin has to be penetrated twice, which may cause less wearing comfort and increased risk of infection.
  • the cost-effective embodiment variation illustrated in Figures 3 and 4 will therefore be well suitable for those applications in which only relatively short wearing times of the device 5 are necessary.
  • Figure 5 shows a further embodiment of the present invention, a reinforcement element 14 made of nonporous material being positioned in the element 6 to be positioned subcutaneously.
  • the reinforcement element 14 is preferably produced from the same material as the element 6, only without pores.
  • the element 6 made of porous material may, for example, be produced by sintering plastic, ceramic, or metal. In this case, areas without porosity may also be produced in the element 6, so that it is also conceivable to integrate the reinforcement element 14 in the element 6 and produce them in one procedure.
  • the porosity may vary depending on the location of the element 6 and, for example, a porosity gradient may be produced which supports the delivery of the substances 9 and the extraction of the bodily substances 22.
  • the attachment element 16 comprises, as shown in Figure 6B, a hole 43 discharging into the cavity 17 of the inlet tube 19 and a hole 44 positioned at the front end of the end of the porous tube 15, which is connected to a hole 45 discharging into the drain line 12.
  • the substances 9 to be delivered may be conveyed via the cavity 17 of the inlet tube 19 to the free end 18 of the inlet tube 19 and porous tube 15 and conducted from there via the inlets 7 into the porous material of the tube 15.
  • the substances 9 to be delivered may pass from the porous material into the subcutaneous tissue 2 and also the substances 22 may pass from the subcutaneous tissue 2 into the porous material.
  • the extracted bodily substances 22 and possibly the not delivered residue of the substances 9 are drained via the drain line 12 attached to the outlet 10 at the end of the tube 15.
  • the flow of the substances 9 to be delivered and the extracted bodily substances 22 is illustrated on the basis of the arrows in Figure 6A.
  • the tube 15 and/or the inlet tube 19 are preferably made of stiff materials and the free ends 18 of the porous tube 15 and nonporous inlet tube 19 are implemented as beveled, so that the device 5 may be penetrated into the subcutaneous tissue 2 without further aids.
  • the embodiment variation shown in Figures 6A and 6B may be introduced by the patient himself into the subcutaneous tissue 2 and used for delivery of a substance 9, such as insulin.
  • An essential advantage of this embodiment variation in relation to the transcutaneous needle 1 according to the prior art is the additional possibility of the removal of bodily substances 22, such as glucose, for the purpose of measuring the tissue glucose concentration. Because of the rigidity of the materials used, however, the embodiment variation according to Figure 6 has a restricted wearing comfort comparable to the transcutaneous needle 1 shown in Figure 1.
  • FIGs 7 A and 7JB show a further embodiment of the device 5 according to the invention, the porous tube 15 and the nonporous inlet tube 19 preferably being made of flexible material, which allows more comfortable wearing of the device 5.
  • a stiff needle 20 is inserted into the cavity 17 of the inlet tube 19 via a hole 26, and the device 5 is inserted into the subcutaneous tissue 2 with the aid of the needle 20.
  • the needle 20 is removed in accordance with Figure 7B and the hole 26 is closed by a cover element 21.
  • the embodiment variation in accordance with Figures 7 A and 7B may be introduced by the patient himself into the -subcutaneous-tissue 2-and-used-for_ delivery of substances 9.
  • An essential advantage of this embodiment variation in relation to the transcutaneous cannula according to the prior art is, however, the additional possibility of removing bodily substances 22. Therefore, the device 5 is suitable, for example, for use for the therapy of diabetes, since insulin or another glucose-regulating medication may be delivered to the subcutaneous tissue 2 and the glucose concentration in the tissue fluid may also be ascertained.
  • FIGS. 8A and 8B show a further embodiment of a device 5, the nonporous inlet tube 19 being implemented as a needle 20 movable in the porous tube 15, in contrast to the variation shown in Figure 6.
  • the needle 20 is positioned in accordance with Figure 8A for insertion, so that its tip projects beyond the tube 15 made of porous material and easier introduction of the device 5 into the subcutaneous tissue 2 is thus made possible.
  • the needle 20 is retracted somewhat, so that the tip of the needle 20 is also enclosed by the porous tube 15 and therefore more comfortable wearing of the device 5 is made possible.
  • the supply line for the substances 9 in the attachment 16 also corresponds to a hole 23 in the needle 20, so that the substances 9 may be conveyed via the cavity 17 of the needle 20 to the free end 18 of the porous tube 15.
  • At least one hole 24 may be positioned at the tip of the needle 20, which makes the redirection of the substances 9 into the porous material of the tube 15 easier.
  • Figures 9A and 9B show the device 5 according to Figure 8A during use in a vessel 25, such as a blood vessel, wherein according to Figure 9 A, the needle 20 being positioned in such a way that its tip projects beyond the tube 15 made of porous material and the insertion into the vessel 25 is thus made easier.
  • the needle 20 is removed and a substance 9 is introduced into the vessel 25 via the cavity 17 of the porous tube 15. Blood may also be suctioned out of the vessel 25 via the cavity 17, for example.
  • Substances 22 of the blood may be drained via a drain line 12 in the attachment element 16 connected to the tube 15 made of porous material and supplied to an analysis, for example. If the pore size of the porous material of the tube 15 is selected so that blood cells (e.g., erythrocytes) may not penetrate into the porous material, for example, blood plasma may be suctioned off via the drain line 12.
  • blood cells e.g., erythrocytes
  • Figure 10 shows the device 5 in accordance with Figure 6 during use in a vessel 25, a substance 9 being able to be introduced into the vessel 25 via the cavity 17 of the inlet tube 19 according to Figure 10. Blood may also be suctioned out of the vessel 25 via the cavity 17. If the pore size of the porous material of the tube 15 is selected so that blood cells (e.g., erythrocytes) may not penetrate into the pores of the tube 15, blood plasma may be suctioned off via the drain line 12 connected to the attachment element 16, for example.
  • blood cells e.g., erythrocytes
  • Figures 1 IA and 1 IB show a variant of a device 5 which is suitable for delivery of substances 9 to vessels 25 and for removal of blood plasma from the same vessels 25.
  • a cannula 3 made of nonporous material is introduced into the vessel 25 with the aid of a needle 20.
  • the needle 20 is removed and, corresponding to Figure 1 IB, an element 27 made of porous material is introduced into the cannula 3 and fixed using an attachment element 28.
  • the dimension of the element 27 is selected in such a way that a gap 29 remains free between the inner wall of the cannula 3 and the element 27 made of porous material, into which the blood may penetrate.
  • Figure 12 shows a use of the device 5 according to the invention for delivery of substances 9, such as insulin, to the subcutaneous tissue 2 and for extraction of bodily substances 22, such as tissue glucose, from the subcutaneous tissue 2.
  • the device 5 is penetrated and fixed in the subcutaneous tissue 2 and connected to the device 30 via lines 29.
  • Containers 31, 32 which contain the substance 9 to be delivered to the subcutaneous tissue 2, are located in the housing 42 of the device 30.
  • the containers 31, 32 preferably contain the substance 9 in different concentrations.
  • the substance from the container 31 or 32 conveyed by a pump 34, reaches the device 5 via a changeover switch 33 and is at least partially delivered to the subcutaneous tissue 2.
  • bodily substances 22 of the subcutaneous tissue 2 are extracted via the tube 15 made of porous material and, also conveyed by the pump 34, supplied to a sensor 35 for measuring the tissue concentration of the bodily substances.
  • the tissue fluid reaches the collection container 36.
  • the containers 31 and 36 and/or 32 and 36 may be formed by a shared container 37 and/or 38, a movable wall 39 being able to be provided for separating the substance 9 in the container 31 and/or 32 and the collected cleaning or tissue fluid in the container 36.
  • a regulatory unit 40 receives the values measured by the sensor 35, such as a glucose sensor, and regulates the quantity of the substance 9 and/or the insulin to be delivered through corresponding switching of the changeover switch 33.
  • a unit 46 for calibrating the measurement of the tissue concentration of the bodily substances 22 is advantageously also provided, which may be formed, for example, by a unit for measuring the conductivity of the collected tissue fluid. Furthermore, a unit 41 for supplying electrical power is provided, which is preferably formed by rechargeable accumulators.
  • the housing 42 of the device 30 may be sealed and may be made of biocompatible material, such as titanium, to allow implantation.
  • Figure 13 shows a further variant of the use of the device 5 according to the invention for delivery of a substance 9, such as insulin, to the subcutaneous tissue 2 and for extracting bodily substances 22, such as tissue glucose, from the subcutaneous tissue 2.
  • the embodiment variation shown in Figure 13 has two pumps 34, 34' and only one container 31 for the substance 9 to be delivered to the subcutaneous tissue 2.
  • the pumps 34, 34' are provided for the separate conveyance of the substance 9 to be delivered from the container 31 to the device 5 and for conveying the bodily substance 22 from the device 5 to the sensor 35.
  • the (rotational) speed of the pump 34 for conveying the substance 9 to be delivered is regulated in accordance with the measured tissue concentrations of the bodily substances 22.
  • the (rotational) speed of the pump 34' for conveying the bodily substances 22 may also be regulated by the regulatory unit 40. Using this arrangement, a very high efficiency in the delivery of the substance 9 may be achieved.
  • Figure 14 shows a further variant of the use of the device 5 according to the invention for delivery of a substance 9, such as insulin, to the subcutaneous tissue 2 and for measuring bodily substances 22, such as tissue glucose, in the subcutaneous tissue 2.
  • a substance 9 such as insulin
  • bodily substances 22, such as tissue glucose in the subcutaneous tissue 2.
  • the sensor 35 and possibly the calibration unit 46 are integrated in the device 5.
  • the sensor 35 and possibly the calibration unit 46 are preferably attached in the wall of the porous tube 15.
  • the signals from the sensor 35 and possibly the calibration unit 46 are transmitted via a line 44 to the regulatory unit 40. In this case, the transmission of the signals may be performed electrically or optically.
  • the substances 9 to be delivered are brought to the end of the inlet line 13 and conducted from there through the porous element 6 in the direction of the opposing beginning of the drain line 12, so that during the traversal of the porous element 6 the substances 9 may be delivered to the tissue 2 or vessel 25 and bodily substances 22 may be extracted from the tissue 2 or vessel 25 via the mantle surface of the porous element 6. The extracted bodily substances 22 may then be drained via the drain line 12 from the beginning of the drain line 12.

Abstract

La présente invention concerne un dispositif (5) destiné à la distribution de substances (9) et à l'élimination de substances corporelles (22) à partir d'un tissu (2) ou d'un vaisseau (25) d'un corps en utilisant un élément (6) devant être positionné dans le tissu (2) ou le vaisseau (25). Afin de proposer un dispositif de ce type pour la distribution et l'élimination de substances (9, 22), qui présente une construction petite et robuste et peut être utilisé aussi facilement et confortablement que possible par le patient, l'élément (6) est au moins partiellement fait d'un matériau poreux et comprend au moins une admission (7) destinée à fournir la substance (9) devant être distribuée et au moins une sortie (10) destinée à drainer les substances corporelles (22). L'admission (7) peut être raccordée par l'intermédiaire d'une ligne d'admission (13) à un récipient pour les substances (9) devant être distribuées, de sorte que dans l'éventualité d'un gradient de pression entre l'admission (7) et la sortie (10), la substance (9) devant être distribuée lors de la traversée de l'élément poreux (6) est délivrée par l'intermédiaire de la surface périphérique de l'élément poreux (6) vers le tissu (2) ou le récipient (25) et les substances corporelles (22) sont extraites du tissu (2) ou du vaisseau (25) par l'intermédiaire de la surface périphérique de l'élément poreux (6) et drainées par l'intermédiaire d'une ligne de drain (12) pouvant être raccordée à la sortie (10).
PCT/EP2006/006568 2005-07-06 2006-07-05 Dispositif et procédé de distribution et d'élimination de substances provenant et à destination d'un tissu ou d'un vaisseau WO2007003431A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP06762426A EP1898799A1 (fr) 2005-07-06 2006-07-05 Dispositif et procédé de distribution et d'élimination de substances provenant et à destination d'un tissu ou d'un vaisseau
US11/994,739 US20080234563A1 (en) 2005-07-06 2006-07-05 Device for and Method of Delivery and Removal of Substances in and From a Tissue or Vessel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT11402005 2005-07-06
ATA1140/2005 2005-07-06

Publications (2)

Publication Number Publication Date
WO2007003431A1 true WO2007003431A1 (fr) 2007-01-11
WO2007003431A9 WO2007003431A9 (fr) 2007-03-01

Family

ID=37072558

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/006568 WO2007003431A1 (fr) 2005-07-06 2006-07-05 Dispositif et procédé de distribution et d'élimination de substances provenant et à destination d'un tissu ou d'un vaisseau

Country Status (3)

Country Link
US (1) US20080234563A1 (fr)
EP (1) EP1898799A1 (fr)
WO (1) WO2007003431A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009049823A1 (fr) * 2007-10-16 2009-04-23 Werner Regittnig Cathéter et procédés pour l'utiliser et le fabriquer
WO2014018595A1 (fr) * 2012-07-26 2014-01-30 Twin Star Medical, Inc. Cathéter macroporeux

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008048183A1 (fr) * 2006-10-18 2008-04-24 Cma/Microdialysis Ab Cathéters de microdialyse et procédé de fabrication d'un cathéter de microdialyse
EP2338408A1 (fr) * 2009-12-24 2011-06-29 Roche Diagnostics GmbH Dispositif d'injection mesurable
US9409006B2 (en) * 2011-04-10 2016-08-09 David Hirshberg Fat removal device and obesity treatment
WO2012156478A1 (fr) * 2011-05-17 2012-11-22 Joanneum Research Forschungsgesellschaft Mbh Cathéter ayant un leurre de cicatrisation
TWI735138B (zh) * 2019-08-02 2021-08-01 華廣生技股份有限公司 生理訊號傳感裝置

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3112762A1 (de) 1981-03-31 1983-01-13 Jürgen Dr.med. 8700 Würzburg Schrezenmeir Doppellumen-blutentnahme-einfachlumen-infusions-subclavia-katheterset
DE4001760A1 (de) * 1989-02-08 1990-08-09 Avl Medical Instr Ag Vorrichtung zur bestimmung zumindest einer medizinischen messgroesse
US5002054A (en) 1987-02-25 1991-03-26 Ash Medical Systems, Inc. Interstitial filtration and collection device and method for long-term monitoring of physiological constituents of the body
US5257980A (en) 1993-04-05 1993-11-02 Minimed Technologies, Ltd. Subcutaneous injection set with crimp-free soft cannula
US5325867A (en) 1990-06-01 1994-07-05 Avl Medical Instruments Ag Device for withdrawing body fluids
DE4401400A1 (de) * 1994-01-19 1995-07-20 Ernst Prof Dr Pfeiffer Verfahren und Anordnung zur kontinuierlichen Überwachung der Konzentration eines Metaboliten
US5741284A (en) 1994-02-04 1998-04-21 Cma/Microdialysis Holding Ab Dialysis combination and microdialysis probe and insertion device
EP0958780A1 (fr) 1998-05-20 1999-11-24 Disetronic Licensing AG Système à capteur avec accès permanemment implanté
US20010047170A1 (en) 1999-02-04 2001-11-29 Branco Antonio Carlos Kit for endovascular venous surgery
US6706009B2 (en) 2000-02-25 2004-03-16 Disetronic Licensing Ag Micro perfusion device
US20040057876A1 (en) * 2002-07-31 2004-03-25 Thomas Wuske Device and process for collecting and releasing saliva

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2262568A (en) * 1939-10-21 1941-11-11 Kenneth L Wade Ear protector
US2441866A (en) * 1943-06-04 1948-05-18 Jacob J Cantor Device for protecting the ear drum
GB853241A (en) * 1958-02-17 1960-11-02 Jose Maria Capdevila Mirabet An applicator for use in the ear
IT1142930B (it) * 1981-11-04 1986-10-15 Luigi Bernardi Apparecchio portatile che infonde insulina sulla base dei rilevamenti glicemici
US4531088A (en) * 1982-08-06 1985-07-23 Allied Corporation Blood analysis
US5256418A (en) * 1990-04-06 1993-10-26 Organogenesis, Inc. Collagen constructs
US5394886A (en) * 1993-09-20 1995-03-07 Nabai; Hossein Skin biopsy plug and method
CA2378678C (fr) * 1999-06-08 2009-08-04 Broadley Technologies Corporation Electrode de reference a jonction a ecoulement liquide microfluidique
US7890295B2 (en) * 2000-02-23 2011-02-15 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
US7264723B2 (en) * 2002-11-01 2007-09-04 Sandia Corporation Dialysis on microchips using thin porous polymer membranes
JP2007508552A (ja) * 2003-10-10 2007-04-05 プロテイン・デイスカバリー・インコーポレーテツド マトリックス支援レーザー脱離／イオン化（ｍａｌｄｉ）質量分析法（ｍｓ）を包含する化学分析のための被検体の濃縮および精製のための方法および装置

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3112762A1 (de) 1981-03-31 1983-01-13 Jürgen Dr.med. 8700 Würzburg Schrezenmeir Doppellumen-blutentnahme-einfachlumen-infusions-subclavia-katheterset
US5002054A (en) 1987-02-25 1991-03-26 Ash Medical Systems, Inc. Interstitial filtration and collection device and method for long-term monitoring of physiological constituents of the body
DE4001760A1 (de) * 1989-02-08 1990-08-09 Avl Medical Instr Ag Vorrichtung zur bestimmung zumindest einer medizinischen messgroesse
US5325867A (en) 1990-06-01 1994-07-05 Avl Medical Instruments Ag Device for withdrawing body fluids
US5257980A (en) 1993-04-05 1993-11-02 Minimed Technologies, Ltd. Subcutaneous injection set with crimp-free soft cannula
DE4401400A1 (de) * 1994-01-19 1995-07-20 Ernst Prof Dr Pfeiffer Verfahren und Anordnung zur kontinuierlichen Überwachung der Konzentration eines Metaboliten
US5741284A (en) 1994-02-04 1998-04-21 Cma/Microdialysis Holding Ab Dialysis combination and microdialysis probe and insertion device
EP0958780A1 (fr) 1998-05-20 1999-11-24 Disetronic Licensing AG Système à capteur avec accès permanemment implanté
US20010047170A1 (en) 1999-02-04 2001-11-29 Branco Antonio Carlos Kit for endovascular venous surgery
US6706009B2 (en) 2000-02-25 2004-03-16 Disetronic Licensing Ag Micro perfusion device
US20040057876A1 (en) * 2002-07-31 2004-03-25 Thomas Wuske Device and process for collecting and releasing saliva

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1898799A1

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009049823A1 (fr) * 2007-10-16 2009-04-23 Werner Regittnig Cathéter et procédés pour l'utiliser et le fabriquer
WO2014018595A1 (fr) * 2012-07-26 2014-01-30 Twin Star Medical, Inc. Cathéter macroporeux
US9821141B2 (en) 2012-07-26 2017-11-21 Twin Star Medical, Inc. Macroporous catheter

Also Published As

Publication number Publication date
EP1898799A1 (fr) 2008-03-19
US20080234563A1 (en) 2008-09-25
WO2007003431A9 (fr) 2007-03-01

Similar Documents

Publication Publication Date Title
EP1549242B1 (fr) Capteur implantable
CA2458966C (fr) Procede et systeme d'implantation d'une sonde non vasculaire
CA2424288C (fr) Dispositif et procede de prelevement de fluide interstitiel d'un patient pour tests diagnostiques
US6254586B1 (en) Method and kit for supplying a fluid to a subcutaneous placement site
US8388584B2 (en) Method and system for the use of hollow fiber catheters in topical applications
EP2709704B1 (fr) Cathéter ayant un leurre de cicatrisation
US20080234563A1 (en) Device for and Method of Delivery and Removal of Substances in and From a Tissue or Vessel
EP0134758A2 (fr) Dispositif d'infusion contrôlée d'insuline ou de glucose chez les diabétiques
EP2023994B1 (fr) Cathéter à fente de forme oblongue
US20020183604A1 (en) Apparatus for access to interstitial fluid, blood, or blood plasma components
WO2009049823A1 (fr) Cathéter et procédés pour l'utiliser et le fabriquer
WO2007054317A1 (fr) Determination de la valeur d'un parametre physiologique
JPH02246986A (ja) 生体内案内具
JP2022103268A (ja) インプラント可能なアクセスチャンバ及び関連する使用方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006762426

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWP Wipo information: published in national office

Ref document number: 2006762426

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11994739

Country of ref document: US